Heart Disease Clinical Trials in Massachusetts

Showing 101-120 of 451 trials

Rehabilitation at Home Using Mobile Health In Older Adults After Hospitalization for Ischemic Heart Disease

NCT03978130

RESILIENT is a phase II, multi-center, prospective, pragmatic randomized clinical trial with blinded assessment of the primary endpoint. This study aims to evaluate whether mHealth-CR improves functional capacity in older adults (age ≥65) with IHD compared with standard traditional cardiac rehabilitation care. A total of 400 eligible patients will be randomized in 3:1 manner to mHealth-CR versus usual care for assessment of primary endpoint. Enrollment will occur over approximately 42 months with an expected minimum of 3 months follow-up per participant.

Ischemic Heart Disease

NYU Langone Health400 participantsStarted Jan 2020

Worcester, Massachusetts, United States • New York, New York, United States

Active Not RecruitingPhase 318 miles

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

NCT05882045

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD). The study will last about 113 weeks.

ObesityCardiovascular Diseases

Eli Lilly and Company1,800 participantsStarted May 2023

Phoenix, Arizona, United States • Covina, California, United States • Fresno, California, United States +166 more locations

Rehabilitation at Home Using Mobile Health In Older Adults After Hospitalization for Ischemic Heart Disease

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Heart Disease Trials in Other Cities

Optisure Lead Post Approval Study

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

Long Term Follow Up for CTSN Mitral Valve Repair Studies

Global Utilization And Registry Database for Improved heArt preservatioN

Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

SURPASS Impella 5.5 Study

Effects of Gender-Affirming Hormone Therapy Among Transgender Women

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

Predictive Value of Coronary Heart Disease (CHD) Biomarkers for CHD Death

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Heart Failure Optimization Study

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

RADIQAL Study (Radiation Dose and Image Quality Trial)

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

Conduction System Pacing Optimized Therapy

Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood Flow and Reserve

Abbott Vascular Medical Device Registry

Other Conditions in Massachusetts